Meet FHMRI researcher Dr. Luke Grundy, who is working at the intersection of neuroscience, urology, immunology and cancer research to improve the lives of patients living with bladder pain. His research spans from uncovering the fundamental mechanisms that control how bladder nerves function in health and chronic pain, through to developing translational therapies aimed at improving patient quality of life.
“There’s a common misconception that once cancer treatment ends, people simply return to normal life,” Dr. Grundy said. “But many patients continue living with severe pain and long-term side effects caused by the treatment itself.”
As Head of the NeuroUrology Research Group at Flinders University, Dr. Grundy leads a multidisciplinary team investigating how the nerves of the bladder contribute to chronic pain, urinary dysfunction, and treatment-related complications. His research focuses on developing new therapies that not only improve cancer survival, but also quality of life after treatment.
A key part of this work is partnering with consumers and advocacy groups to ensure research remains focused on the challenges that matter most to patients. Through a close collaboration with BEAT Bladder Cancer Australia, a FHMRI research partner, Dr. Grundy and his team engage directly with people affected by bladder cancer to help shape research priorities and improve patient outcomes.
“Up to 20% of patients stop bladder cancer treatment early because the pain and urinary symptoms become too severe,” he explained. “We want to find ways to prevent those side effects before they become debilitating.”
Supported through the Ralph Ernst Fellowship, made possible by a legacy gift to the Flinders Foundation, and successful grants from Cancer Council NSW, Dr. Grundy and his team are unravelling the mechanisms underlying the development of bladder pain during bladder cancer treatment, and whether existing pain-relief therapies can be repurposed to improve patient outcomes.
His research also extends into urinary tract infections (UTIs), where his team has uncovered how a specific subtype of sensory nerves are responsible for signalling infections, contributing to the development of pain and bladder dysfunction.
“We’re beginning to understand how inflammation and infection fundamentally alter the way sensory nerves communicate with the brain,” Dr. Grundy said. “That opens the door to developing far more targeted and effective treatments.”
Passionate about mentoring the next generation of scientists, Dr. Grundy works closely with students, researchers, and clinicians across immunology, microbiology, oncology, and neuroscience to tackle complex clinical problems through collaborative research.
“I’d like the future of cancer care to be about more than survival,” he said. “It should be about helping people truly recover and thrive after treatment.”